Crossmark

Biosimilar medicines: Impact, opportunities and strategies. Twelve years of experience in Europe

Crossref DOI link: https://doi.org/10.1016/j.medcle.2018.11.021

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Delgado Sánchez, Olga

Ginard Vicens, Daniel

Sampol Mayol, Antonia

Terrasa Pons, Josefa
License Information

Text and Data Mining valid from 2019-05-01
More Information

This article is maintained by: Elsevier

Article Title: Biosimilar medicines: Impact, opportunities and strategies. Twelve years of experience in Europe

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2018.11.021

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2018.11.013

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. All rights reserved.